BioPharma« Terug naar discussie overzicht

1. [verwijderd] 15 maart 2007 13:51

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   (ouder bericht)
   
   eFoodSafety.com, Inc.'s Cinnergen(TM) Sales Gain Momentum through Inclusion in AmeriMark Catalogues
   Thursday March 1, 9:45 am ET
   
   Healthy Living, the Time For Me and Feel Good Store Catalogues Provide Exposure of Cinnergen(TM) to More Than 5 Million Readers per Month
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF - News), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that Cinnergen(TM) can now be found in the AmeriMark catalogues. In addition to Healthy Living, the Time For Me and Feel Good Store catalogues provide the potential of over 5 Million readers per month to be introduced to Cinnergen(TM), the Company's clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism.
   
   AmeriMark advised that it added Cinnergen to the Time For Me (http://www.timeformecatalog.com) and Feel Good Store (http://www.feelgoodstore.com) catalogues because the sales of Cinnergen(TM) from the Healthy Living (http://www.amerimark.com) catalog were both profitable and growing.
   
   Patricia Gruden, President and CEO of eFoodSafety.com, Inc. stated, "We are pro-actively broadening the marketing of Cinnergen(TM) to catalog sales, a traditionally stable and necessary base that is an essential part of any national marketing plan. In its 37 year history, AmeriMark has established an excellent reputation within the print industry for offering quality brand-name merchandise at an exceptional value. We're cautiously optimistic that this recent expansion into AmeriMark's additional catalogs has the potential to fuel sales growth of Cinnergen(TM), resulting in incremental revenue growth within this sales channel."
   
   About AmeriMark
   
   AmeriMark Direct is a leading direct marketer of women's apparel, shoes, name-brand cosmetics, fragrances, jewelry, watches, accessories, and health-related merchandise. AmeriMark Direct has been providing a large selection of quality value priced, brand-name merchandise to its satisfied customers since 1969. AmeriMark Direct ships millions of packages to its satisfied customers each year. Its reputation carries over to its website, (http://www.amerimark.com), which was created in October 2000 to give customers a safe and convenient place to shop online. With over 6000 items from 6 of their distinctive catalogs, Amerimark.com provides one convenient location to shop an exceptional selection of merchandise at bargain prices.
   
   About eFoodSafety.com, Inc.
   
   eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The Company is also owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Cinnechol(TM), a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.
   
   Please visit the Company's website at: www.efoodsafety.com.
2. [verwijderd] 15 maart 2007 13:53

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   (ouder bericht)
   
   eFoodSafety.com, Inc. Adds Over 1,000 Retail Locations to its Retail Distribution Network for Cinnergen(TM)
   Thursday February 1, 9:20 am ET
   Hy-Vee Supermarket Stores, H-E-B Stores and Vitamin World Added to List of Retailers as Regional and National Chains Continue to Embrace Clinically-Studied and Proven Effective Product
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF - News), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that Hy-Vee Supermarket Stores, H-E-B Stores, and Vitamin World have been added to the growing list of retailers featuring Cinnergen(TM), the Company's clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism. The Company also reported that additional regional retailers are being added daily.
   
   Patricia Gruden, President and CEO of eFoodSafety.com, Inc., stated, "The response for the product has been overwhelmingly positive. The addition of new regional and national retail chains to our already strong distribution network is highly encouraging. We remain focused on continuing to build the Cinnergen brand as well as maximizing product sell through."
   
   Gruden further stated, "In order to continue to further fuel the products rapid growth, we expect to maintain and strengthen our advertising efforts in support of both our regional retailers and our national retailers."
   
   About Hy-Vee
   
   Hy-Vee, an employee-owned company based in Chariton, Iowa is known for excellent service and low prices with more than 49,000 employee-owners to help guide the company. With sales of more than $4.6 billion and more than 200 retail stores across seven Midwestern states, Hy-Vee ranks among the top 15 supermarket chains in the nation. For more information about Hy-Vee, please visit www.hy-vee.com.
   
   About H-E-B
   
   For more than 100 Years, H-E-B has been an innovative retailer. Known for its fresh food, quality products, convenient services, and a commitment to environmental responsibility and sustainability, H-E-B strives to provide the best customer experience at every day low prices. Based in San Antonio, H-E-B employs more than 60,000 Partners and serves millions of customers in more than 150 communities throughout Texas and Mexico. For more information about H-E-B, please visit www.heb.com.
   
   About Vitamin World
   
   To provide a fast and convenient way to shop at home for vitamins, Vitamin World operates one of the most sophisticated and efficient automated fulfillment systems in the business. Each day, the automated fulfillment system, which was designed, in part, by its own engineers, picks over 100,000 products and ships them to over 15,000 households. Vitamin World also owns and operates over 550 retail stores nationwide. Established over 40 years ago and headquartered in Long Island, N.Y., Vitamin World manufactures over 1,000 high quality vitamins, minerals, herbs, and other nutritional supplements in their own state-of-the-art facilities. For more information about Vitamin World, please visit www.vitaminworld.com.
   
   About eFoodSafety.com, Inc.
   
   eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) -- EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The Company is also the owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol(TM), a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.
   
   Please visit the Company's website at: www.efoodsafety.com.
3. [verwijderd] 15 maart 2007 14:34

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   De afgelopen twee maanden een dikke 100% erbij. Ergens deze/volgende week cijfers, die naar verwachting niet spectaculair zullen zijn.
   
   Voor dit kwartaal wordt nog wel de aankondiging van de lancering van pureffect (acnemiddel met een geschat marktpotentieel van enige 100en miljoenen - en de kosten worden gedragen door de JV partner - verwacht, inclusief de celebrity die de ruggegraat van de campagne gaat vormen.)
   
   Tussen nu en een paar weken tevens het finaliseren van de licensing agreement met de USDA m.b.t. oraphyte, een gewasbeschermingsmiddel dat onschadelijk is voor de ozonlaag, en door het US Department of Agriculture positief is getest.
   
   Ook in de pijplijn tussen nu en een maand: het afslankmiddel Cinnegol, waarvan de afzet wellicht kan worden bevorderd door het al bestaan en groeien van een distributienetwerk voor Cinnergen.
   
   En als wildcard is daar natuurlijk het vogelgriep konijn in de Thaise hoge hoed, waaromheen het maar stilletjes is...
   
   Wie weet, wie weet...
   
   
4. [verwijderd] 20 maart 2007 19:42

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Quarterly report - weinig spectakel
   
   biz.yahoo.com/e/070319/efsf.ob10qsb.html
5. [verwijderd] 20 maart 2007 19:45

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   En...Dupont gaat Oraphyte - het middel tegen Nematoden (gewasbescherming) dat door de US Department of Agriculture al als 'effectief' getest is (met USDA wordt eind deze maand een licensing agreement verwacht) - testen. Oraphyte is itt de meeste andere middelen, niet schadelijk voor de ozonlaag.
   Geen kleine markt, en indien het tot een partnerschap komt, geen kleine partner.
   (Zie ook het bericht van januari)
   
   eFoodSafety.com, Inc. and DuPont Sign Agreement to Evaluate and Test eFoodSafety.com, Inc.'s OraPhyte(TM)
   Tuesday March 20, 9:30 am ET
   DuPont, a Fortune 100 Company Received Samples of OraPhyte(TM) for Testing on Plant-Parasitic Nematodes at DuPont Research Center
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF - News), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that the Company and DuPont (NYSE:DD - News) have entered into a written agreement whereby DuPont will evaluate and conduct additional testing on OraPhyte(TM) to determine its effectiveness in controlling plant-parasitic nematodes. The USDA has successfully tested OraPhyte(TM) and DuPont will independently test OraPhyte(TM) to reaffirm the results. Upon completion of testing, the parties anticipate additional negotiations to define the parameters for commercialization and to enter into a marketing or licensing agreement. Testing is currently being conducted by DuPont at the DuPont Research Center in Newark, DE.
   
   ADVERTISEMENT
   Patricia Gruden, President and CEO of eFoodSafety.com, Inc. stated, "We are obviously very excited to have OraPhyte(TM) evaluated at the DuPont Research Center. DuPont's name recognition and credibility along with their marketing and financial capabilities have the potential to add significant value to our efforts to establish this product as a leading choice in the fight and control of plant-parasitic nematodes."
   
   Robert Bowker, President of the Company's wholly-owned subsidiary Knock-Out Technologies, Ltd., and the formulator of OraPhyte(TM), stated, "I'm optimistic that DuPont will find OraPhyte(TM) valuable for their purposes. We believe OraPhyte(TM) is an effective, environmentally-safe product that can treat this $100 Billion worldwide problem of plant-parasitic nematodes. My research has found no other product in the marketplace with the capabilities of OraPhyte(TM)."
   
   About DuPont
   
   DuPont (http://www.dupont.com) is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. DuPont is a world leader in the development and manufacturing of high-performance materials that provide environmentally sustainable solutions utilizing renewable, farm-grown feedstocks rather than petroleum. The power of DuPont's scientific capabilities, including state-of-the-art biotechnology and bio-based manufacturing processes, are being harnessed to meet the needs of both customers and society.
   
   About eFoodSafety.com, Inc.
   
   eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The Company is also owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol(TM), a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.
   
   Please visit the Company's website at: www.efoodsafety.com.
   
   Safe Harbor Forward-Looking Statements
   
   Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
6. [verwijderd] 27 maart 2007 21:12

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Als er een wk persberichten uitbrengen bestond, zou efsf meedingen naar de titel, maar goed, er is blijkbaar een hoop positief nieuws te melden. Het wordt nu tijd voor de eerste goeie cash flow.
   
   eFoodSafety.com, Inc. Formulates All-Natural Cold Remedy
   Monday March 26, 9:30 am ET
   Company Takes Aim at the Common Cold Costing U.S. Economy $40B with Introduction of All-Natural Chewable Lozenge Featuring Citroxin O2
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB: EFSF - News), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that it has formulated a novel all-natural cold remedy in the form of a chewable lozenge featuring Citroxin O2. Citroxin O2 is an all-food grade formula, containing no chemicals or pharmaceuticals. It has been proven one hundred percent effective in vitro by independent laboratory testing against many pathogens, including: Staph Aureus, Streptococcus Pneumoniae, and Pseudomonas Aeruginosa. Citroxin O2 has proven anti-viral capability, a vital necessity as 200 different known viruses can cause the common cold.
   
   ADVERTISEMENT
   This Citroxin O2 formula will contain Zinc, several vital electrolytes, vitamin C and immune enhancing probiotics. As a lozenge, the unique benefits of Citroxin O2 and synergistic ingredients will begin working immediately in the membranes of the sinuses and oral cavity to help reduce both the severity and duration of the cold virus.
   
   The common cold with its nagging and oftentimes severe symptoms is pervasive in society. Every year, the U.S. population experiences up to one billion colds. Although colds can happen anytime, they occur most often in the winter and spring. Annually, approximately 189 million school days are lost to colds with another 126 million days of work lost for at least one parent to stay home to tend to their sick child. Up to the age of 17, the number of colds caught per year is 5-12. People above the age of 18 catch 2-4 colds per year.
   
   The economic impact of the common cold is staggering. Studies have shown that in the U.S. on a yearly basis, $2.9 billion is spent on OTC cold remedies, $400 million on prescriptions, and another $1.1 billion on anti-biotic prescriptions to treat secondary bacterial infections due to colds. Approximately 100 million visits are paid to the doctor each year from contracting a cold, resulting in a cost of about $7.7 billion. All told, it is estimated that the annual cost to the U.S. economy from the common cold equals about $40 billion each year.
   
   Patricia Gruden, President and CEO of eFoodSafety.com, Inc. stated, "We're pleased to introduce this new product to our expanding and evolving list of better health related offerings. We anticipate commencing clinical trials on this product within the next 60 days."
   
   Gruden further commented, "It's an exciting time here at eFoodsafety.com as evidenced by many of our announcements of recent months. Having now established a strong distribution channel for Cinnergen(TM) including some of the top retailers in the world, we believe the potential for cross-selling opportunities is high. We have established a strong foundation allowing us to leverage future growth and we are now seeing tangible results in the form of increasing sales. We anticipate reporting the increasing revenues in forthcoming quarters having already experienced the typical 60-90 day lag time from initial sale to collection of the receivable allowing us to physically book the revenues."
   
   About eFoodSafety.com, Inc.
7. [verwijderd] 27 maart 2007 21:14

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Dit m.b.t tot de te verwachten groei van de cash flow:
   
   `Gruden further commented, "It's an exciting time here at eFoodsafety.com as evidenced by many of our announcements of recent months. Having now established a strong distribution channel for Cinnergen(TM) including some of the top retailers in the world, we believe the potential for cross-selling opportunities is high. We have established a strong foundation allowing us to leverage future growth and we are now seeing tangible results in the form of increasing sales.
   
   We anticipate reporting the increasing revenues in forthcoming quarters having already experienced the typical 60-90 day lag time from initial sale to collection of the receivable allowing us to physically book the revenues."`
8. [verwijderd] 27 maart 2007 21:16

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Hé Connect,
   Zit je er alweer in?
   
   
9. [verwijderd] 1 mei 2007 23:37

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   eFoodSafety.com Launches National Public Relations Campaign to Increase Public Awareness of the Company and its Innovative Products
   Monday April 2, 9:30 am ET
   
   SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF - News), a natural health company dedicated to improving health conditions around the world through innovative products and technologies, today announced it has engaged Pitch Inc. to launch a national multifaceted publicity campaign about the latest technologies and products being developed by eFoodSafety.
   
   ADVERTISEMENT
   The year-long campaign will focus on communicating the nutritional benefits of two of eFoodSafety's products, Cinnergen, a non-prescription whole food nutritional supplement that promotes healthy glucose metabolism, and Cinnechol, a nutritional supplement designed to reduce cholesterol levels. The goal of the campaign is to increase exposure through the media of the company's product launches, existing products and the company as a whole, in order to raise awareness among consumers and the investment community about eFoodSafety and its innovative technologies and products.
   
   "eFoodSafety has several impressive and important health products and technologies that are not widely known among consumers and the investment community," says Amy Summers, president of Pitch Inc. "We are excited to work with eFoodSafety to raise public awareness on these innovations that we believe will have widespread media appeal."
   
   Pitch Inc., a public relations firm, provides companies with highly effective publicity campaigns specifically designed to help increase product sales, market share and profitability. The company has executed numerous national publicity campaigns for clients in a variety of fields including medical/health, food/beverage, business/finance, entertainment and non-profit organizations.
   
   With over 25 clients in the natural products industry, Pitch has a proven record of success in communicating key brand messages through the media to increase consumer awareness about the health benefits of natural products.
   
   Patricia Gruden, President and CEO of eFoodSafety.com, Inc. stated, "We are pleased to be working with Pitch, Inc. at this crucial stage in the Company's development and now feel we are ready to present a concise message to the investment community and consumers. The Board of Directors and I felt that Pitch, Inc., with its extensive and impressive national media contact list, was the correct public relations firm to carry out the Company's message."
   
   About eFoodSafety.com, Inc.
   
   eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The Company is also owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol(TM), a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.
   
   Please visit the Company's website at: www.efoodsafety.com.
   
   Safe Harbor Forward-Looking Statements
10. [verwijderd] 1 mei 2007 23:37

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    eFoodSafety.com, Inc.'s Cinnergen(TM) to be Featured on ``The Price is Right'' Game Show Nationwide
    Monday April 23, 9:45 am ET
    "Greatest Game Show of All Time" Seen Daily by 5.8 Million People to Include Cinnergen(TM) in its Pricing Game
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF - News), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that Cinnergen(TM), the Company's all-natural dietary supplement clinically proven to promote healthy glucose metabolism and lower blood sugar levels in as little as 7 days, will be featured on The Price is Right Game Show.
    
    Cinnergen(TM) will be included in one of the show's well known pricing games. The Price is Right show highlighting Cinnergen(TM) will air the week of April 30, 2007 and the week of May 7, 2007. The Price is Right, televised by CBS, is seen nationwide Monday through Friday. It is seen daily by an estimated 5.8 million people. The Price is Right is one of the highest rated shows in daytime TV and consistently has a daytime projected Nielsen House Hold rating point of 4.2. With this affiliation of Cinnergen(TM) and The Price is Right, awareness of Cinnergen(TM) will continue to grow on a national level.
    
    Patricia Gruden, President and CEO of eFoodSafety.com, Inc., stated, "We are extremely pleased with our progress of continuing to aggressively build the Cinnergen(TM) brand and retail distribution network. Since just December, we have successfully expanded the Cinnergen(TM) distribution network to include Kroger's, Cardinal Health, USA Drug, Dr. Leonard's, CVS.com, Amazon.com, drugstore.com, and AmeriMark Catalogues all of which are seeing the brand gain retail traction. Importantly, not only does this established distribution network bode well for the sales of Cinnergen(TM), but it also has significant value as we launch and cross-sell new product offerings."
    
    Gruden further commented, "On the back of our notable recent progress, having Cinnergen(TM) featured on The Price is Right, the longest running game show in North American television, is something we're very excited about. We believe it will further complement and supplement existing efforts to grow the brand while simultaneously introducing eFoodSafety.com to a mass audience as a company dedicated to improving health conditions around the world."
    
    Named by TV Guide as the "greatest game show of all time," The Price is Right has the distinction of being one of only two game shows to be seen in first run network or syndication airings in every decade since the 1950's.
    
    The current version is hosted by Bob Barker, winner of 17 Daytime Emmy Awards and has been on since 1972. This version is the longest running game show in the history of North American television.
    
    The Price is Right is produced by The Price is Right Productions, a joint venture of RTL Group and CBS.
    
    About eFoodSafety.com, Inc.
    
    eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The Company is also owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol(TM), a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.
    
    Please visit the Company's website at: www.efoodsafety.com.
11. [verwijderd] 1 mei 2007 23:38

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    eFoodSafety.com, Inc. Announces Cinnergen(TM) Sales Gaining Momentum
    Tuesday May 1, 9:45 am ET
    Cinnergen(TM) Weekly Sales Beginning to Show Double Digit Increases Throughout April
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB: EFSF - News), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that the sales of Cinnergen(TM), the Company's all-natural dietary supplement clinically proven to promote healthy glucose metabolism and lower blood sugar levels in as little as 7 days, are gaining momentum while showing consistent double-digit weekly sales increases.
    
    The Company also announced its national advertising campaign is scheduled to launch next week corresponding with Cinnergen(TM) being featured in one of the pricing games on The Price is Right. The Price is Right, televised by CBS, is seen nationwide Monday through Friday by an estimated 5.8 million people.
    
    Patricia Gruden, President and CEO of eFoodSafety.com, Inc., stated, "We are pleased to be realizing the eagerly awaited tangible results of many long hours of hard work. Product sales through our national retail distribution network are increasing and gaining the anticipated weekly momentum and our catalog sales continue to show strong growth. Our previously stated goal of having Cinnergen(TM) in over 20,000 retail locations by year is not only on track but it's happening faster than originally anticipated."
    
    Gruden further commented, "I believe the investment community and our valued shareholders will soon come to realize that the Company's previous investments in product development and infrastructure, although impacting near-term profitability, will result in the creation of long term sustainable value. We anticipate reporting dramatic improvements in the company's balance sheet within the next 30 days."
    
    About eFoodSafety.com, Inc.
    
    eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The Company is also owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol(TM), a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.
    
    Please visit the Company's website at: www.efoodsafety.com.
12. [verwijderd] 29 juni 2007 19:33

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    eFoodSafety.com, Inc. Announces Retirement of 100% of Company Debt
    Wednesday May 9, 9:40 am ET
    Company Successfully Retires over $1.5 Million in Long and Short-Term Debt at a Conversion Price $0.55 Per Share
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB: EFSF - News), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that the Company has successfully retired all of its long and short-term debt.
    
    The Company's debt, consisting of $1.5 million in long and short-term debt, has been voluntarily converted by the debt holders into restricted shares at a fixed price of $0.55 per share representing a significant premium to the current market price of the company's common stock.
    
    Patricia Gruden, President and CEO of eFoodSafety.com Inc., stated, "The non-convertible debenture holders approached the Company in March 2007 regarding a conversion of their debt. They expressed their desire to hold restricted shares of the Company's common stock rather than senior debt. The Company worked diligently to convert this debt viewing it as a mutually beneficial opportunity."
    
    Patricia Gruden further stated, "We're obviously very pleased to announce the conversion of our outstanding debt under these very favorable terms. The Company now boasts a strong balance sheet allowing us to take full advantage of the multitude of opportunities to maximize future growth for the Company as well as building value for its shareholders. We continue to remain optimistic about the future as Cinnergen(TM) sales continue to show strong growth, the Immune Boost Bar is only months away from launch and our testing with DuPont on OraPhyte(TM) is on-going as planned."
    
    About eFoodSafety.com, Inc.
    
    eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The Company is also owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol(TM), a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.
    
    Please visit the Company's website at: www.efoodsafety.com.
    
    Safe Harbor Forward-Looking Statements
    
    Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
    
    
13. [verwijderd] 29 juni 2007 19:33

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Form 8-K for EFOODSAFETY COM INC
    
    21-Jun-2007
    
    Changes in Registrant's Certifying Accountant, Financial Statements and Exhib
    
    Item 4.01. Changes in Registrant's Certifying Accountant
    
    On June 19, 2007, Robison, Hill & Co., the Company's principal independent accountant, was dismissed by the Board of Directors, and E. Randall Gruber, CPA, PC was engaged to audit the Company's financial statements.
    
    The former accountant's report on the Company's financial statements for the past two fiscal years, April 30, 2005 and 2006, did not contain an adverse opinion or disclaimer of opinion, but the report did refer to Note 1 to the financial statements which stated: "These accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. As of April 30, 2006 [April 30, 2005], the Company has accumulated operating losses of $16,043,832 [$6,662,936] since its inception. The continuation of the Company is dependent upon the continuing financial support of directors and stockholders." These conditions raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments that might arise from this uncertainty."
    
    There were no disagreements with the former accountant on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure during the two most recent fiscal years ended April 30, 2006 or during the interim period ended June 19, 2007, nor were there any reportable events during those periods.
    
    The Company did not consult with E. Randall Gruber, CPA, PC during the past two fiscal years or during the interim period ended June 19, 2007 regarding the application of accounting principles to a specific completed or contemplated transaction, or the type of audit opinion that might be rendered, and neither written nor oral advice was provided as to an accounting, auditing or financial reporting issue.
    
    The Company has requested Robison, Hill & Co to review the foregoing disclosure and to provide the Company with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the statements made and, if not, the respects in which it does not agree. The letter is filed as an exhibit to this report.
    
    Item 9.01. Financial Statements and Exhibits
    
    The following exhibits are filed as part of this report:
    
    16.1 Letter from Robison, Hill & Co.
14. [verwijderd] 29 juni 2007 19:34

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    eFoodSafety.com, Inc. Retains 26-Year DuPont Veteran for Global Commercialization of OraPhyte(TM) to the $100 Billion Nematode Market
    Thursday June 28, 9:45 am ET
    
    SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB: EFSF - News) is pleased to announce that Dr. Madon M. Joshi, Ph.D., formerly employed as a researcher and Worldwide Licensing Manager for New Technology at DuPont, has retired from DuPont and has contracted with eFoodSafety.com, Inc. to further develop and license OraPhyte(TM), an environmentally-safe product for treating the $100 billion worldwide problem of plant-parasitic nematodes.
    
    ADVERTISEMENT
    On March 20, 2007, eFoodSafety.com announced entering into a written agreement with DuPont to evaluate and conduct additional testing on OraPhyte(TM) to determine its effectiveness in controlling plant-parasitic nematodes. Upon completion of testing, the parties anticipate entering into negotiations to define the parameters for commercialization and to enter into a marketing or licensing agreement.
    
    Dr. Joshi was retained by eFoodSafety as a continuation of its efforts to commercialize OraPhyte(TM). Dr. Joshi had been with DuPont for the past 26 years, serving as a researcher and Worldwide Licensing Manager for New Technology. He was responsible for numerous multi-million dollar commercialization and development projects.
    
    Dr. Joshi stated, "After years of dealing with the difficult problem of plant parasitic nematodes, I am pleased to be working with an environmentally responsible product that has the potential to reduce the problem worldwide."
    
    Patricia Gruden, CEO of eFoodSafety.com, Inc., "We are proud and honored to have Dr. Joshi become part of the eFoodSafety.com team. He has extensive experience in the agricultural product development field and bringing new and innovative technologies to the market place. His professionalism and knowledge will be paramount in bringing our patent-pending revolutionary product OraPhyte(TM) to the global plant-parasitic nematode market."
    
    About eFoodSafety.com, Inc.
    
    eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The Company is also owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol(TM), a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.
    
    Please visit the Company's website at: www.efoodsafety.com.
    
    Safe Harbor Forward-Looking Statements
    
    Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
    
    
15. [verwijderd] 29 juni 2007 19:36

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Laatste bericht interessant.
    Als het in dienst treden van de Worldwide Licensing Manager for New Technology van Dupont een duidelijke hint is dat er een deal met Dupont op stapel staat v.w.b. het middel tegen Nematoden, dan wordt het knallen.
    
    (Zijn we weer even bij.)